Who owns the CLINICAL MAESTRO trademark?

The CLINICAL MAESTRO trademark is owned by Strategikon, Inc..

What class is the CLINICAL MAESTRO trademark registered in?

The CLINICAL MAESTRO trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CLINICAL MAESTRO?

The USPTO serial number for CLINICAL MAESTRO is 90080624.

What is the registration number for CLINICAL MAESTRO?

CLINICAL MAESTRO is registered under USPTO registration number 6414880.

Sealvo

Home Search: CLINICAL MAESTROCLINICAL MAESTRO #90080624

Back

Updated Oct 17, 2026·14 searches this week

View on USPTO TSDR Find similar marks

CLI

USPTO Trademark Record

REGISTERED

CLINICAL MAESTRO

SN 90080624·Reg 6414880·Filed Jul 29, 2020

Owner Strategikon, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CLINICAL MAESTRO (Serial No. 90080624), Registration No. 6414880, is a registered US trademark filed on Jul 29, 2020 by Strategikon, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Renewal window: July 13, 2027269 days remaining

Mark Intelligence

CLINICAL MAESTRO (Reg. #6414880) is a registered US trademark that has been protecting its owner, Strategikon, Inc., since 2020. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 29, 2020

SERIAL

90080624

REG#

6414880

REGISTERED

Jul 13, 2021

Filing Information

StatusREGISTERED

Filing DateJul 29, 2020

Serial Number90080624

Registration No.6414880

Registration DateJul 13, 2021

Status DateJul 13, 2021

Published for OppositionApr 27, 2021

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application Currently

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1660680

480Dec 31, 2021

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Feb 12, 2018

First use in commerce: Feb 12, 2018

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

21 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jul 13, 2026

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Jul 13, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Apr 27, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 27, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 07, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 23, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 22, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Mar 20, 2021

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 20, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

FINAL REFUSAL WRITTEN

Mar 01, 2021

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Mar 01, 2021

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Mar 01, 2021

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 02, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 01, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 01, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Nov 20, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Nov 20, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 20, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Nov 13, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 27, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 01, 2020

NEW APPLICATION ENTERED

Other Marks by Strategikon, Inc.

Additional USPTO filings from the same owner.

CLI

CLINICAL MAESTRO

90075663

Strategikon, Inc.

REGISTERED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

CLI

CLINICAL MAESTRO

90075663

Strategikon, Inc.

REGISTERED

MAE

MAESTRO

99633192

Monetate, Inc.

REGISTERED

MAE

MAESTRO

97151590

StratusOn LLC

REGISTERED

MAE

MAESTRO

88923790

MAARK, LLC

REGISTERED

CLINICAL MAESTRO

Run a conflict check

Other Marks by Strategikon, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company